RGEN insider transactions
Repligen Corporation (RGEN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for RGEN
- SEC Form 4 filed by Loeillot Olivier4 - REPLIGEN CORP (0000730272) (Issuer)
- SEC Form 4 filed by Kuriyel Ralf4 - REPLIGEN CORP (0000730272) (Issuer)
- SEC Form 4 filed by Loeillot Olivier4 - REPLIGEN CORP (0000730272) (Issuer)
- SEC Form 4 filed by Bylund James4 - REPLIGEN CORP (0000730272) (Issuer)
- SEC Form 4 filed by Garland Jason K4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Operating Officer Bylund James was granted 125 shares and covered exercise/tax liability with 62 shares, increasing direct ownership by 0.36% to 17,672 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Senior VP, R&D Kuriyel Ralf was granted 125 shares and covered exercise/tax liability with 42 shares, increasing direct ownership by 0.56% to 14,778 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Operating Officer Bylund James covered exercise/tax liability with 3,911 shares, decreasing direct ownership by 18% to 17,609 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Executive Officer Loeillot Olivier covered exercise/tax liability with 1,954 shares, decreasing direct ownership by 5% to 33,944 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony covered exercise/tax liability with 9,897 shares, decreasing direct ownership by 10% to 89,062 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- CFO Garland Jason K covered exercise/tax liability with 1,042 shares, decreasing direct ownership by 8% to 12,341 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Senior VP, R&D Kuriyel Ralf covered exercise/tax liability with 1,367 shares, decreasing direct ownership by 9% to 14,695 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- CHIEF PRODUCT OFFICER Douglass Brian Robb covered exercise/tax liability with 221 shares, decreasing direct ownership by 3% to 8,319 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- CHIEF PRODUCT OFFICER Douglass Brian Robb was granted 2,288 shares, increasing direct ownership by 37% to 8,540 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- New insider Douglass Brian Robb claimed ownership of 6,252 shares (SEC Form 3)3 - REPLIGEN CORP (0000730272) (Issuer)
- Director Dawes Karen A sold $44,275 worth of shares (275 units at $161.00), decreasing direct ownership by 0.30% to 91,821 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Muir Glenn P exercised 3,366 shares at a strike of $26.12, increasing direct ownership by 10% to 36,622 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony disposed of 2,000 shares (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Executive Officer Loeillot Olivier sold $1,196,970 worth of shares (7,041 units at $170.00), decreasing direct ownership by 16% to 35,898 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Operating Officer Bylund James sold $331,301 worth of shares (2,191 units at $151.21), decreasing direct ownership by 9% to 21,520 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony sold $3,092,278 worth of shares (20,000 units at $154.61) and exercised 2,952 shares at a strike of $33.87, decreasing direct ownership by 17% to 83,695 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony exercised 25,000 shares at a strike of $33.87 and sold $3,921,940 worth of shares (25,000 units at $156.88) (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Executive Officer Loeillot Olivier covered exercise/tax liability with 1,248 shares, decreasing direct ownership by 3% to 42,939 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- CFO Garland Jason K covered exercise/tax liability with 412 shares, decreasing direct ownership by 3% to 13,383 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony sold $3,508,389 worth of shares (29,111 units at $120.52) and exercised 20,000 shares at a strike of $33.87, decreasing direct ownership by 8% to 100,743 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- CHIEF ACCOUNTING OFFICER Hughes Violetta was granted 4,142 shares (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Executive Officer Loeillot Olivier covered exercise/tax liability with 2,506 shares, decreasing direct ownership by 5% to 44,187 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- SEC Form 3 filed by new insider Hughes Violetta3 - REPLIGEN CORP (0000730272) (Issuer)
- Director Madaus Martin D bought $201,830 worth of shares (1,800 units at $112.13) (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Barthelemy Nicolas was granted 973 shares, increasing direct ownership by 28% to 4,441 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Konstantinov Konstantin was granted 973 shares, increasing direct ownership by 51% to 2,894 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Muir Glenn P was granted 973 shares, increasing direct ownership by 3% to 33,256 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Eglinton Manner Carrie was granted 973 shares, increasing direct ownership by 28% to 4,466 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Dawes Karen A was granted 973 shares, increasing direct ownership by 1% to 92,096 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Madaus Martin D was granted 973 shares, increasing direct ownership by 21% to 5,586 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Pax Margaret was granted 973 shares, increasing direct ownership by 93% to 2,016 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Mhatre Rohin was granted 973 shares, increasing direct ownership by 32% to 4,019 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony sold $3,271,688 worth of shares (26,447 units at $123.71), decreasing direct ownership by 19% to 109,854 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Operating Officer Bylund James covered exercise/tax liability with 454 shares, decreasing direct ownership by 2% to 23,711 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Operating Officer Bylund James was granted 381 shares and covered exercise/tax liability with 175 shares, increasing direct ownership by 0.86% to 24,165 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony sold $4,080,663 worth of shares (26,756 units at $152.51) and exercised 26,756 shares at a strike of $54.73 (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Pax Margaret bought $37,672 worth of shares (250 units at $150.69), increasing direct ownership by 32% to 1,043 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- CFO Garland Jason K was granted 6,435 shares, increasing direct ownership by 87% to 13,795 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Senior VP, R&D Kuriyel Ralf was granted 4,826 shares and covered exercise/tax liability with 386 shares, increasing direct ownership by 38% to 16,062 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony covered exercise/tax liability with 10,142 shares, decreasing direct ownership by 7% to 136,301 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Operating Officer Bylund James was granted 6,435 shares and covered exercise/tax liability with 1,239 shares, increasing direct ownership by 28% to 23,959 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Executive Officer Loeillot Olivier was granted 14,480 shares, increasing direct ownership by 45% to 46,693 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- CFO Garland Jason K covered exercise/tax liability with 316 shares, decreasing direct ownership by 4% to 7,360 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Executive Officer Loeillot Olivier covered exercise/tax liability with 343 shares, decreasing direct ownership by 1% to 32,213 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Operating Officer Bylund James covered exercise/tax liability with 1,285 shares, decreasing direct ownership by 6% to 18,763 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Senior VP, R&D Kuriyel Ralf covered exercise/tax liability with 391 shares, decreasing direct ownership by 3% to 11,622 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony covered exercise/tax liability with 2,825 shares, decreasing direct ownership by 2% to 146,443 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Senior VP, R&D Kuriyel Ralf covered exercise/tax liability with 275 shares, decreasing direct ownership by 2% to 12,013 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Operating Officer Bylund James covered exercise/tax liability with 543 shares, decreasing direct ownership by 3% to 20,048 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony covered exercise/tax liability with 2,380 shares, decreasing direct ownership by 2% to 149,268 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony exercised 11,808 shares at a strike of $33.87, increasing direct ownership by 8% to 151,648 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Hunt Anthony exercised 24,246 shares at a strike of $33.87 and sold $3,386,439 worth of shares (24,246 units at $139.67) (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- CFO Garland Jason K covered exercise/tax liability with 367 shares, decreasing direct ownership by 5% to 7,676 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Chief Executive Officer Loeillot Olivier covered exercise/tax liability with 861 shares, decreasing direct ownership by 3% to 32,556 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)
- Director Muir Glenn P exercised 19,000 shares at a strike of $36.29, increasing direct ownership by 143% to 32,283 units (SEC Form 4)4 - REPLIGEN CORP (0000730272) (Issuer)